Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?

Dirk Hellwig, Thomas P. Graeter, Dieter Ukena, Andreas Groeschel, Gerhard W. Sybrecht, Hans-Joachim Schaefers and Carl-Martin Kirsch
Journal of Nuclear Medicine November 2007, 48 (11) 1761-1766; DOI: https://doi.org/10.2967/jnumed.107.044362
Dirk Hellwig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas P. Graeter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dieter Ukena
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Groeschel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard W. Sybrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Joachim Schaefers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl-Martin Kirsch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    18F-FDG PET in lymph node staging of lung cancer: unaffected lymph nodes (N0), peribronchial or hilar lymph node involvement (N1), ipsilateral mediastinal and subcarinal involvement (N2), and contralateral and supraclavicular involvement (N3).

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Comparison of maximum SUV in mediastinal lymph nodes. FN = false-negative; TN = true-negative; FP = false-positive; TP = true-positive.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    ROC curves for semiquantitative SUV analysis and visual interpretation of 18F-FDG PET images for mediastinal lymph node staging in patients with lung cancer. Intensity of lesion was visually compared with that of mediastinal blood pool and scored from + + + to − − −.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    Error rates and diagnostic accuracy of lymph node characterization by 18F-FDG PET as function of SUV threshold applied.

Tables

  • Figures
    • View popup
    TABLE 1

    Results of Characterization of Mediastinal Lymph Nodes by Visual Interpretation of 18F-FDG PET and Correlation with Pathologic Diagnosis

    18F-FDG PET (visual interpretation)
    All lymph nodesLung cancer patients
    StatusNegativePositiveTotalNegativePositiveTotal
    Benign243 TN58 FP301205 TN36 FP241
    Metastasis6 FN64 TP706 FN64 TP70
    Total249122371211100311
    • FN = false-negative; TN =true-negative; FP = false-positive; TP = true-positive.

    • View popup
    TABLE 2

    Diagnostic Performance of 18F-FDG PET in Assessment of Mediastinal Lymph Nodes of Lung Cancer

    IndexVisual interpretation (%)SUV cutoff of 2.5 (%)
    Sensitivity91 (85–98)89 (81–96)
    Specificity85 (81–90)84 (79–88)
    Accuracy87 (82–91)85 (81–89)
    Positive predictive value64 (55–73)61 (52–71)
    Negative predictive value97 (95–99)96 (94–99)
    • Values in parentheses are 95% confidence intervals.

    • View popup
    TABLE 3

    Results of Characterization of Mediastinal Lymph Nodes by SUV Analysis of 18F-FDG PET and Correlation with Pathologic Diagnosis

    18F-FDG PET (semiquantitative analysis)
    All lymph nodesLung cancer patients
    StatusSUV < 2.5SUV ≥ 2.5TotalSUV < 2.5SUV ≥ 2.5Total
    Benign238 TN63 FP301202 TN39 FP241
    Metastasis8 FN62 TP708 FN62 TP70
    Total246125371210101311
    • FN = false-negative; TN =true-negative; FP = false-positive; TP = true-positive.

    • SUV threshold of 2.5 was used for differentiation between benign and metastatic lymph nodes.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (11)
Journal of Nuclear Medicine
Vol. 48, Issue 11
November 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?
Dirk Hellwig, Thomas P. Graeter, Dieter Ukena, Andreas Groeschel, Gerhard W. Sybrecht, Hans-Joachim Schaefers, Carl-Martin Kirsch
Journal of Nuclear Medicine Nov 2007, 48 (11) 1761-1766; DOI: 10.2967/jnumed.107.044362

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?
Dirk Hellwig, Thomas P. Graeter, Dieter Ukena, Andreas Groeschel, Gerhard W. Sybrecht, Hans-Joachim Schaefers, Carl-Martin Kirsch
Journal of Nuclear Medicine Nov 2007, 48 (11) 1761-1766; DOI: 10.2967/jnumed.107.044362
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
  • N3 hilar sampling decision in the staging of mediastinal lung cancer
  • Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
  • Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node Staging
  • Role of 18F-FDG-PET/CT in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
  • 68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer
  • Large Decreases in Standardized Uptake Values After Definitive Radiation Are Associated with Better Survival of Patients with Locally Advanced Non-Small Cell Lung Cancer
  • Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non-Small Cell Lung Cancer Tumor Delineation
  • 18F-FDG PET SUVmax Correlates with Osteosarcoma Histologic Response to Neoadjuvant Chemotherapy: Preclinical Evaluation in an Orthotopic Rat Model
  • The Effectiveness of 18F-FDG PET/CT Combined with STIR MRI for Diagnosing Nodal Involvement in the Thorax
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire